RayzeBio (NASDAQ:RYZB) Downgraded to “Market Perform” at William Blair
William Blair lowered shares of RayzeBio (NASDAQ:RYZB – Free Report) from an outperform rating to a market perform rating in a report released on Tuesday, MarketBeat Ratings reports. William Blair also issued estimates for RayzeBio’s FY2023 earnings at ($3.25) EPS, Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at ($0.09) EPS, Q4 2024 earnings […]
More Stories
US Stocks Soar, Oil Prices Plunge as Market Fears of Israel–Iran Conflict Spreading Fade: Analyst
By Andrew Moran U.S. stocks surged at the start of the trading week, rebounding from Friday’s selloff sparked by geopolitical...
German Police Shut Down Darknet Marketplace Selling Drugs
By Chris Summers One of the world’s biggest darknet marketplaces for fentanyl and other drugs, Archetyp, has been taken down...
South Africa’s Emotional WTC Triumph: Proteas Win First Major Cricket Trophy in 27 Years
By The Associated Press LONDON—South Africa on Saturday claimed its first major cricket trophy in 27 years when it wrapped...
Trump Says US-UK Trade Deal ‘Signed and Done’ at G7 Summit
By Emel Akan CALGARY, Canada—President Donald Trump announced on Monday that the recently finalized UK-US bilateral trade agreement is “signed...
Former New York Assembly Candidate Charged With Campaign Finance Fraud
By Frank Fang A Chinese national allegedly stole around $162,000 in taxpayer money to fund his 2024 campaign for New...
7 Best Delivery Apps to Make Money in 2025
In the current fast-paced world, side hustles have become an increasingly popular means of earning extra cash, specifically, food delivery...